Effects of the oral endothelin receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension
Authors:
- Nazzareno GalieNGNazzareno Galie
- Alan L. HinderliterAHAlan L. Hinderliter
- Adam TorbickiATAdam Torbicki
- Gerald SimonneauGSGerald Simonneau
- Nilda Espinola-ZabaletaNENilda Espinola-Zabaleta
- Guido RocchiGRGuido Rocchi
- Marcin KurzynaMKMarcin Kurzyna
- Andrew KronenbergAKAndrew Kronenberg
- Robert FrantzRFRobert Frantz
- Nagueh SherifNSNagueh Sherif
- Robyn BarstRBRobyn Barst
- Karl DujardinKDKarl Dujardin